---
title: 'Modelling Costs of Interventional Pulmonary Embolism Treatment: Implications
  of US Trends for a European Healthcare System'
date: '2024-02-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38349225/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240213170620&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our approach and results, which may be adapted to other
  European healthcare systems, provide a benchmark for healthcare costs expected to
  result from CDT. Data from ongoing trials on clinical benefits and cost savings
  are needed to determine cost-effectiveness and inform reimbursement ...'
disable_comments: true
---
CONCLUSION: Our approach and results, which may be adapted to other European healthcare systems, provide a benchmark for healthcare costs expected to result from CDT. Data from ongoing trials on clinical benefits and cost savings are needed to determine cost-effectiveness and inform reimbursement ...